your market intelligence analyst
Search Results
26 results
Your search is now limited to «Excipients» expert search.
Vascular News 10/16/2019 04:27
Philips has received US Food and Drug Administration (FDA) approval for two Stellarex 0.035” low-dose (200mm and 150mm) drug-coated balloons for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries. According to a press release, the new balloons broaden physicians’ treatment options for peripheral artery disease (PAD) patients with […]. .
Vascular News 10/15/2019 11:23
It was recently announced that luminor 18 and luminor 35 DCBs (iVascular), are now listed on the French LPPR list for de novo lesions of the femoro-popliteal arteries. Luminor is a paclitaxel coated balloon specifically designed for dilatation of stenosis located in the iliac, femoral, iliofemoral, popliteal, infrapopliteal and renal arteries, as well as for […]. .

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios